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ABSTRACT: The direct compression ability of pre-gelatinized African bitter yam and cassava starches in 
acetylsalicylic acid tablet formulation was investigated. Starches from the African bitter yam and cassava tubers were 
extracted following standard procedures. The starch powders were subjected to some physicochemical evaluations 
and pre-gelatinized. Batches of acetylsalicylic acid granules and tablets were formulated with the native and pre-
gelatinized forms of both the test and maize starches and microcrystalline cellulose at 5.0 and 10 %w/w by direct 
compression. Granules were evaluated for their flow properties and drug-excipient compatibility using DSC and 
FTIR while the tablets were investigated for their tablet parameters. The extracted starches were off-white to white in 
colour, insoluble in water, smooth in texture with particle sizes ranging from 5.0-10 µm that are oval to elliptical in 
shapes. The powders showed a swelling capacity ≤ 2.15, hydration capacity ≥ 1.20 and a moisture content ≤ 14.3 %. 
The granules exhibited good to fair flowability. Only tablets formulated with 10 %w/w of the pre-gelatinized starches 
and MCC met compendial requirements in their crushing strengths and friability. All the tablets disintegrated within 
15 min with the pre-gelatinized cassava starches giving the shortest times of < 1.0 min. The 10 %w/w pre-gelatinized 
starches tablets compared favourably with MCC in their drug release profiles. Compatibility studies revealed no 
interaction between drug and excipients. The study show that the pre-gelatinized test starches compared favourably 
with MCC, a known direct compression excipient in their direct compression ability and drug release profiles 
especially at a concentration of 10 %w/w. © JASEM 
https://dx.doi.org/10.4314/jasem.v21i5.10 
Keywords: bitter yam, cassava, starches, pre-gelatinized, drug formulation 
 
A tablet is composed of an active or therapeutic 
ingredient(s) and a number of inert materials known 
as excipients or additives. These excipients may be 
classified either as materials that help to impart 
satisfactory processing and compression 
characteristics to the tablet formulation such as 
diluents, binders, glidant and lubricants or as 
materials that help to give additional desirable 
physical characteristics to the finished tablet such as 
disintegrants, colours, flavours and sweetening agents 
(Rudnic and Schwartz, 2006). There are also 
excipients that play two or more roles in a tablet 
formulation. Example of such multifunctional 
excipients is a direct compression excipient which 
may play the role of a diluent, binder and disintegrant 
in a formulation.  
 
Starches are polysaccharides which serve as energy 
storage for most green plants. Apart from being a 
common carbohydrate in diets, it is also widely used 
in the pharmaceutical industries as excipients in tablet 
formulation as disintegrants, binders or lubricants. 
These roles of starch in tablet formulations have 
initiated a search for newer starches of natural origin 
and their modified improved varieties (Kottke et al., 
1992; Odeku et al., 2009; Eraga et al., 2016). Native 
forms of starches are modified physically, 
enzymatically or chemically to improve the utility 
properties of the starch powder (Gotlieb and Capelle, 
2005). Modified starches have been reported to 
improve tablet properties such as compressibility and 
dissolution characteristics in pharmaceutical 
preparations (Mostafa, 2004; Okunlola and 
Akingbala, 2013; Lawal et al., 2015; Akin-Ajani et 
al., 2016). 
 
African bitter yam (Discorea dumetorum) is a root 
crop that grows in various parts of West Africa and it 
is popular in the south eastern part of Nigeria. It is 
cultivated in times of food scarcity or famine as a 
result of scarcity of other varieties of yam. It also 
grows in the wild and the wild specie is toxic (Kay, 
1987). The yams are normally soaked in salt water 
before consumption in order to detoxify and remove 
the bitter components. 
Cassava (Manihot esculenta) is a woody shrub 
cultivated annually in the tropical and sub-tropical 
regions for its edible starchy tuberous root, a major 
source of carbohydrate. It is called tapioca when 
dried and crushed to a powdery substance; its 
fermented, fried granular version is named “garri”. 
Cassava is the third largest source of food 
carbohydrate in the tropics, after rice and maize. It is 
a major staple food in the developing world. 
 
This study is aimed at investigating the direct 
compression property of pre-gelatinized starches 
sourced from African bitter yam and cassava for 
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MATERIALS AND METHODS 
Materials: Acetylsalicylic acid crystals, 
microcrystalline cellulose and n-hexane (BDH 
Chemical Ltd., Poole, England), lactose (Sigma 
Chemicals, St. Louis, USA), maize starch BP 
(Roquette Freres, France), magnesium stearate 
(A.H.A. International Co. Ltd, China), talc (Chemic 
Laboratory Reagents & Fine Chemicals, France), 3.5 
%w/v sodium hypochlorite (Reckitt and Coleman 
Nig. Ltd) were used as received. African bitter yam 
(Discorea dumetorum) and cassava (Manihot 
esculenta) tubers were purchased locally and 
processed in our laboratory. All sieves were BSS 
(Endecotts Ltd. London, England) and water was 
double distilled. 
 
Methods: Extraction of the starches, Tubers weighing 
about 5 kg were peeled, washed and chopped into 
smaller pieces. The pieces were milled into a paste 
using an electric grinder (Moulinex, France). The 
grounded material was slurried with 1 L of water 
containing 30 m1 of 3.5 %w/v sodium hypochlorite 
and allowed to stand overnight. After 16 h, the 
mixture was sieved using a muslin cloth to separate 
the starch from fibrous materials. Excess water was 
added to the resulting starch slurry, stirred and 
allowed to stand for about 4 h for the sedimentation 
of the starch. The supernatant water was decanted 
carefully and fresh excess water was added with 
continuous stirring. The supernatant water was again 
decanted after 3 h. This washing process was 
repeated several times until the supernatant tested 
neutral to pH test strip. The wet mass of the starch 
was air dried for 24 h and then oven dried at 60 °C 
for 1 h. The dried starch was milled into fine powder 
and stored in an airtight container until use. 
 
Characterization of starch powders: Organoleptic 
properties, the taste, odour and colour of the starches 
were assessed by twelve individuals and a matching 
assessment result given by at least ten of the 
individuals was recorded. 
 
Solubility: About 100 mg of starch was placed in 2 ml 
of cold water in a test-tube and shaken. The 
dispersion was filtered and the residue air dried. The 
dried residue and the filter paper were weighed 
(KERRO BL3002, England) and the difference in 
weight was used as a measure of solubility of the 
starch powder. 
 
Chemical test: A 5 ml aliquot of the starch 
suspension was prepared and a few drops of 0.01 M 
iodine solution was added. The resulting colour 
change was recorded. 
 
Microscopy: The starch sample was thinly spread 
over a glass slide and viewed under a light 
microscope (Labo Microsystems GmbH, Germany) 
via a calibrated eyepiece and the sizes and shapes of 
the particles were recorded. 
 
Bulk density: A 30 g quantity of the starch powder 
was poured gently into a 100 ml graduated measure. 
The volume of the powder was read and the bulk 
density calculated. 
 
Tapped density: The measure containing the 30 g of 
starch powder was tapped 100 times on a wooden 
platform to a constant volume. The volume was noted 
and used in calculating the tapped density. 
 
Carr’s index: The difference between the tapped and 
bulk density of the starch powder divided by the 
tapped density was calculated and the ratio expressed 
as percentage. 
 
Hausner’s ratio: The ratio of the tapped density to 
the bulk density of the starch powder was calculated 
as the Hausner’s quotient. 
 
True density: A 25 ml specific gravity bottle (glass 
pycnometer) was filled with n-hexane, cleaned of any 
excess n-hexane and weighed (x). The bottle was 
emptied, rinsed with acetone and dried. About 1 g (y) 
of the starch powder was poured into the bottle and 
then filled with n-hexane. It was weighed (z) after 
cleaning off the excess n-hexane from the bottle. The 
various weights recorded were used to calculate the 
true density of the starch using Equation 1. All the 








=ρ     (1) 
 
 
Where ρ is the particle density of the starch and S is 
the specific gravity of n-hexane 
Swelling capacity: A 10 g weight of the starch 
powder with a tapped volume (VA) in a 100 ml 
measuring cylinder was dispersed with 85 ml of 
distilled water and thereafter made up to volume with 
more water. The dispersion was allowed to stand for 
24 h and the volume of the sediment (VB) noted. The 
swelling capacity was computed with Equation 2. 
Swelling capacity = AB VV −    . . . .   (2) 
Where VB and VA are the volumes of the sediment and 
the tapped starch sample respectively 
 
Hydration capacity: A 1 g weight of the starch was 
introduced into a 15 ml centrifuge tube. The tube was 
covered after 10 ml of water was added and shaken 
for about 2 min. It was allowed to settle for 10 min 
and centrifuged at 2000 rpm for 10 min using a bench 
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centrifuge. The resulting supernatant was decanted 
and the sediment weighed. The hydration capacity 
was determined with Equation 3. This determination 
was carried out in quadruplicate. 





  (3) 
Where WB and WA are the weights of the sediment 
and the starch sample, respectively.  
 
Moisture content: A 1 g quantity of the starch powder 
was dried in a hot air oven for 4 h at 105 ºC. The 
initial weight of the powder and the weight after 
drying were recorded and used to calculate the 
moisture content of the starch powder. 
 
Pre-gelatinization of the starches: A weighed 
quantity of starch was dispersed in 500 ml of water 
contained in a 1 L beaker. The dispersion was placed 
in a hot water bath, thermostated at 80 °C, the pre-
gelatinization temperature of starch. The dispersion 
was stirred continuously until a slightly viscous gel 
was formed. The gel was then transferred to a flat 
stainless steel plate and oven dried (Gallenkamp, UK) 
into flakes at 60 °C for 24 h. Thereafter the flakes 
were powdered and passed through a 100 µm mesh 
screen and stored in an air tight container until 
evaluation. Maize starch BP was also subjected to 
pre-gelatinization for comparison with the test 
starches. 
 
Preparation of granules by slugging: Using the 
formula shown in Table 1, a total of eleven (11) 
batches of acetylsalicylic acid powder blends were 
prepared using 5.0 or 10 %w/w of the native and pre-
gelatinized forms of the test starches, maize starch BP 
and microcrystalline cellulose as the 
disintegrant/binder or direct compression agent. Each 
batch was prepared by dry mixing the required 
quantities of acetylsalicylic acid, lactose and the 
disintegrant/binder powders in a mixer for 10 min. 
The powder blend was compressed into large tablets 
(slugs) using a heavy duty tableting machine (Koln 
Niehi, Germany). The slugs were broken down into 
granules using a mortar and pestle and passed through 
an 850 µm sieve. The glidant (talc) and lubricant 
(magnesium stearate) were weighed and mixed in a 
mortar and then added to the granules in geometric 
proportion and mixed intimately. The granules were 








Table 1: Formula of prepared acetylsalicylic acid 
tablets 
Ingredients Quantity/tablet (mg) 
Acetylsalicylic acid 300 
Lactose 82,67 
Disintegrant/Binder* (5,10 %w/w) 15,30 
Magnesium stearate 3 
Talc 3 
Total 400 
*Disintegrant/Binder: African bitter yam starch 
(native; 5 %w/w, pre-gelatinized; 5 and 10 %w/w) or 
cassava starch (native; 5 %w/w, pre-gelatinized; 5 
and 10 %w/w) or maize starch BP (native; 5 %w/w, 
pre-gelatinized; 5 and 10 %w/w) or microcrystalline 
cellulose (5 and 10 %w/w) 
 
Analysis of granules: Micromeritic properties of 
prepared granules: The bulk and tapped densities of 
the granules were determined using the same methods 
as the starch powders and values obtained were used 
to compute the Carr’s indices and Hausner’s ratios of 
the various batches of the acetylsalicylic acid 
granules. 
 
Angle of repose: The hollow tube method was used. 
A short hollow tube of 3 cm in internal diameter 
sitting on a circular horizontal surface of same 
diameter was filled with granules. The tube was 
vertically withdrawn and allowing excess granules to 
fall off the edge of the circular horizontal surface. 
The heap height was measured. The angle of repose, 




 (h/r)   . . . .   (4) 
 
Where h is the height of the heap of granules and r is 
the radius of the circular base 
 
Flow rate: The funnel method was employed. A glass 
funnel was clamped to a retort stand at a certain 
distance from a horizontal surface. Fifty grams of 
granules was poured into the funnel with its orifice 
blocked with a glass sheet. The glass sheet was 
withdrawn and the granules allowed to fall freely 
under the influence of gravity. The time taken for the 
entire granules to pass through the orifice was 
recorded. This was carried out in triplicate and the 
mean values and standard deviations recorded. 
Drug-excipient interaction studies: In order to 
determine any interactions between acetylsalicylic 
acid and the pre-gelatinized forms of the starches, 
drug-excipients interaction studies were carried out 
on the granules prepared with the pre-gelatinized 
forms of the test starches and pure acetylsalicylic acid 
crystals using DSC and FTIR analyses. The DSC 
analysis was carried out using the Netzsch DSC 
204F1 Phoenix apparatus (Netzsch, Germany). Four 
milligrams of the sample was weighed into an 
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aluminium pan. The seal of the pan was pierced and 
placed in the calorimeter previously calibrated with 
indium and nitrogen as the purge gas. Heating of the 
sample was carried out at the rate of 10 °C per min 
from 30 to 350 °C under nitrogen at a flow rate of 70 
ml/min while the FTIR analysis was done using 
FTIR-4100 Spectrophotometer (Shimadzu Co. 
Japan). Five milligrams of the sample was blended 
with potassium bromide to give a 200 mg weight 
powder. The blended powder was compressed using a 
Sigma KBr press into a tablet, and then placed in the 
sample compartment of the spectrophotometer and 




Compression of granules: Batches of the granules 
were compressed into tablets using a single punch 
tableting machine (F-3 Manesty Machines, UK) at a 
compression pressure of 31 arbitrary units. The die 
volume was adjusted to compress tablets of uniform 
weight by using granules weighing 400 mg. The 
tablets made were then kept in air tight containers and 
stored in a desiccator until evaluation. 
 
Tablet evaluations: The following tests were carried 
out on the compressed tablets employing standard 
procedures: tablet weight uniformity, dimensions, 
crushing strength (hardness), friability, disintegration 
time and dissolution profile (BP, 2003). 
 
Weight uniformity: The weight of each of 20 tablets 
was determined from each batch using an electronic 
balance (College B154, Mettler Toledo, Switzerland) 
and the mean weight and standard deviation were 
computed. 
 
Dimensions: The thickness and diameter of 10 tablets 
from each of the batches were determined using the 
Gallenkamp micrometre screw gauge and the mean 
value and standard deviation were recorded. 
 
Crushing strength: The crushing strength of each of 
ten tablets per batch was determined by diametric 
compression of the tablet until it breaks (Campbell 
Electronics, Model HT-30/50, India). The mean value 
and standard deviation were calculated. 
 
Friability test: The weight of 10 tablets was 
determined on the electronic balance and the tablets 
placed in the drum of a Roche friabilator (Erweka-
ZT4 Heusenstamm, Germany). The apparatus was 
operated at a drum speed of 25 rpm for 4 min. The 
tablets were brought out, de-dusted and reweighed. 
The weight was recorded and friability calculated as 
percentage loss in weight. 
Disintegration time: The disintegration times of six 
tablets per batch of the tablets were determined in 
distilled water at 37 ± 0.5 °C using the disintegration 
apparatus (Veego, India). The time taken for each 
tablet to break down into its primary particles and 
pass through the mesh of the apparatus was recorded 
and used to calculate the average time and standard 
deviation. 
 
Dissolution studies: In vitro dissolution profiles of 
the various batches of the acetylsalicylic acid tablets 
were determined using the USP Type II (paddle) 
method. A dissolution apparatus (Caleva ST7, UK) 
containing 900 ml of 0.1 M HCl solution maintained 
at 37 ± 0.5 °C with a paddle speed of 50 rpm was 
used. The apparatus was operated for 60 min and at 
various time intervals, a 5 ml volume of the 
dissolution fluid was withdrawn and replaced with an 
equivalent volume maintained at same temperature 
(37 ± 0.5 °C). The withdrawn samples were filtered 
and diluted with an equal volume of 0.1 M HCl and 
then hydrolyzed by heating at 90 °C for 2 h. About 
two drops 5 % ferric chloride was added to the 
sample solutions after cooling and their absorbances 
determined at λmax of 540 nm with a UV-VIS 
Spectrophotometer (Shimadzu, Japan). The 
concentration and the percentage of acetylsalicylic 
acid released at each time interval was determined 
using the equation from the standard calibration plot 
earlier obtained from the pure drug. 
 
Statistical analysis: Descriptive statistics using 
Microsoft Excel (2007) was done for all data. Mean 
and standard deviations of replicate determinations 
were computed and reported. Differences between 
mean was determined using one-way ANOVA while 
p ˂ 0.05 was considered significant. 
 
RESULTS AND DISCUSSION 
Starch powder properties: Some physical properties 
of the starch powders studied are shown in Table 2. 
The powder of the African bitter yam starch was off-
white in colour while that of cassava starch was 
white. Both starches were odourless, tasteless and 
smooth in texture. They were insoluble in water and 
gave a blue black colouration with iodine solution. 
Microscopic examination of the starch particles 
showed an oval shape with a size range of 5.0 - 10 
µm for the African bitter yam starch while the 
cassava starch was elliptical in shape with a particle 
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Table 2: Some physicochemical properties of the starch powders studied 
Properties 
Starches 
African bitter yam Cassava 
Organoleptic 
Appearance Off-white White 
Taste Tasteless Tasteless 
Odour Odourless Odourless 
Texture Smooth Smooth 
Chemical 
Solubility (cold water) Insoluble Insoluble 
Test for starch Positive Positive 
Microscopy 
Size range 5.0 - 10 µm 7.0 - 10 µm 
Form Oval Elliptical 
Hilum Stellate Stellate 
Striations Presence of striations Presence of striations 
Powder 
parameters 
Bulk density (g/cm3) 0.43 0.54 
Tapped density (g/cm3) 0.76 0.86 
True density (g/cm3) 1.25 1.52 
Carr’s index (%) 43.42 37.21 
Hausner’s ratio 1.76 1.59 
Swelling capacity 1.11 2.15 
Hydration capacity 1.20 1.50 
Moisture content (%) 14.3 14.1 
 
The cassava starch powders exhibited comparable but 
higher densities than the African bitter yam starch 
and this result may be attributed to the particle shapes 
of the starch promoting an even packing resulting in 
fewer void spaces. The Carr’s indices and Hausner’s 
ratios of the test starch powders showed that the 
cassava starch was better flowing, but generally both 
starch powders had poor flow properties. Also the 
swelling and hydration capacities of the cassava 
starch powder were higher with the swelling capacity 
of cassava starch almost twice that of the bitter yam 
starch. This superior swelling ability of cassava starch  
 
would suggest that this starch would be a good 
candidate as a disintegrant. 
 
Both starches showed similar moisture content values 
≤ 14.3 %. These values were comparable to those 
obtained in a similar study involving different 
cultivars of cassava starch where values ranging from 
9.4 - 13.3 % were recorded (Chitedze et al., 2012). 
 
Granule properties: The results of the flow properties 
of the acetylsalicylic acid granules are presented in  
Table 3  
 

























Native 5 A 0.86 1.05 18.01 1.26 33.64 18.18 
Pre- 
gelatinized 
5 B 0.83 1.05 20.95 1.22 33.25 20.00 
10 C 0.80 1.11 27.00 1.32 33.08 19.38 
Cassava 
Native 5 D 0.86 1.04 20.00 1.25 33.69 14.29 
Pre- 
gelatinized 
5 E 0.83 1.05 20.95 1.21 33.55 20.00 
10 F 0.86 1.05 18.09 1.22 33.51 18.18 
Maize 
Native 5 G 0.83 1.05 20.95 1.26 33.51 16.18 
Pre- 
gelatinized 
5 H 0.80 0.91 12.08 1.14 33.73 19.54 
10 I 0.86 1.17 31.00 1.34 33.47 17.50 
Microcrystalline 
cellulose 
5 J 0.83 1.05 20.95 1.31 33.95 15.38 
10 K 0.80 1.00 20.00 1.25 33.64 20.00 
 
The results show a lower bulk and tapped densities 
for the batches of granules prepared with the native 
starches when compared with those prepared with the 
pre-gelatinized starches at the same concentrations of 
5.0 %w/w, which indicates that the batches of pre-
gelatinized starch granules were more porous and free 
flowing as reflected in their Carr’s indices, Hausner’s 
ratios, angles of repose and flow rates (Chitedze et 
al., 2012). But the batches of granules produced with 
higher concentrations of the pre-gelatinized starches 
(10 %w/w) showed a decrease in granule porosity and 
consequently a reduction in their flow properties 
when compared with the 5.0 %w/w batches of 
granules. This observation suggests an increase in the 
cohesiveness and a resultant densification of the 
granule particles with increase in the concentration of 
the pre-gelatinized starches (Abdulsamad et al., 
2008). The batches of granules produced with 
microcrystalline cellulose showed an increase in flow 
characteristics with increase in concentration. 
Generally, all the batches of granules were 
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comparable in their Carr’s indices, Hausner’s ratios, 
angles of repose and flow rates. 
 
Compatibility studies: Thermal analysis; 
Thermograms from the DSC compatibility analysis 
are shown in Figure 1 (a-d). Pure acetylsalicylic acid 
crystal thermogram (Figure 1 (a)) showed a sharp 
endothermic trough corresponding to 175 °C on the 
temperature scale. The sharp trough appeared as a 
spike which is an indication of its crystallinity and 
purity. The thermograms of the granules containing 
the combination of acetylsalicylic acid and the pre-
gelatinized starches of bitter yam (Figure 1 (b)), 
cassava (Figure 1 (c)) and maize (Figure 1 (d)) 
showed the characteristic trough of pure 
acetylsalicylic acid. This observation suggests no 
interaction between the drug and the pre-gelatinized 
starches.  
FTIR: The FTIR spectrum of pure acetylsalicylic acid 
(Figure 2 (a)) crystals showed characteristic 
absorption bands at 918.50, 1195.00, 1300.91, 
1688.26, 1759.81 and 3010.00 cm
-1
. These bands 
observed for acetylsalicylic acid remained unchanged 
when compared with the spectral data of the granules 
containing the combination of acetylsalicylic acid and 
the pre-gelatinized starches of bitter yam (Figure 2 
(b)), cassava (Figure 2 (c)) and maize (Figure 2 (d)) 
starches. This observation ruled out the possibility of 
chemical interaction and complex formation between 
acetylsalicylic acid and the pre-gelatinized starches 
during the mixing process. 
 
 
Fig 1: DSC thermograms of pure acetylsalicylic acid 
crystals (a) and the tablet granules prepared with pre-




Fig 2: FTIR spectra of pure acetylsalicylic acid 
crystals (a) and the tablet granules prepared with pre-
gelatinized starches of bitter yam (b), cassava (c) and 
maize (d) 
 
Tablet properties: The results from the evaluation of 
the various batches of the directly compressed 
acetylsalicylic acid tablets are outlined in Table 4. 
The tablet weight uniformity results showed that the 
mean weight of the tablets prepared with the test 
starches, maize starch BP and microcrystalline 
cellulose met the British Pharmacopoeia (BP 2009) 
specification of not more than two of the individual 
weights of tablets deviating from the average weight 
by more than ± 5 % and none should deviate by more 
than ± 10 %. 
 

















A 405 ± 0.32 12.56 ± 0.04 2.31 ± 0.09 3.72 ± 0.1 1.6 ± 0.5 480 ± 4.0 
B 402 ± 0.11 12.45 ± 0.06 2.23 ± 0.04 3.60 ± 0.1 1.4 ± 0.3 420 ± 2.0 
C 401 ± 0.14 12.53 ± 0.03 2.46 ± 0.02 4.20 ± 0.2 0.9 ± 0.2 180 ± 1.0 
Cassava 
D 404 ± 0.55 12.63 ± 0.07 2.99 ± 0.07 3.52 ± 0.1 1.6 ± 0.6 48 ± 4.0 
E 404 ± 0.16 12.98 ± 0.09 2.32 ± 0.03 3.20 ± 0.1 1.0 ± 0.2 47 ± 5.0 
F 402 ± 0.40 12.02 ± 0.05 2.64 ± 0.03 4.09 ± 0.8 0.9 ± 0.2 33 ± 4.0 
Maize 
G 407 ± 0.20 12.53 ± 0.03 2.23 ± 0.04 3.70 ± 0.1 2.0 ± 0.4 180 ± 1.0 
H 401 ± 0.44 12.57 ± 0.05 2.95 ±0.05 3.10 ± 0.1 1.7 ± 0.2 77 ± 2.0 
I 401 ± 0.42 12.59 ± 0.06 2.95 ± 0.05 4.00 ± 0.1 1.9 ± 0.2 73 ± 3.0 
Microcrystalline 
cellulose 
J 408 ± 0.32 12.45 ± 0.06 2.35 ± 0.09 4.00 ± 0.1 2.0 ± 0.4 160 ± 1.0 
K 413 ± 0.10 12.56 ± 0.04 2.46 ± 0.02 4.30 ± 0.2 0.9 ± 0.1 110 ± 2.0 
± Standard deviation 
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Table 5:  ANOVA results for tablet crushing strength, friability and disintegration time 















Between Groups 4.819084848 10 0.481908485 484.8469512 2.14435E-23 2.296695957 
Within Groups 0.021866667 22 0.000993939 
   
Total 4.840951515 32 









Between Groups 5.592121212 10 0.559212121 22.9156836 2.27573E-09 2.296695957 
Within Groups 0.536866667 22 0.02440303 
   
Total 6.128987879 32 














Between Groups 688713.8788 10 68871.38788 5398.469834 6.98569E-35 2.296695957 
Within Groups 280.6666667 22 12.75757576 
   
Total 688994.5455 32 
    
SS = sum of squares; df = degree of freedom; MS = mean square; F = calculated F-value 
 
Whereas there were variations in the crushing strengths, friability and disintegration times of the formulated 
batches of tablets as confirmed in the significant differences (p < 0.05) between their mean values shown by the 
analysis of variance in Table 5. All the batches of tablets showed crushing strength values > 3.0 kp. Only those 
batches of tablets prepared with microcrystalline cellulose and 10 %w/w of the pre-gelatinized starches of both 
the test starches and maize starch BP gave satisfactory crushing strength values ≥ 4 kp. The friability test results 
of the tablets revealed values ≤ 2.0 % with only tablet batches prepared with 10 %w/w of both microcrystalline 
cellulose and the test starches meeting the British Pharmacopoeia (BP 2009) specification of 0.8 - 1.0 %. The 
acceptable crushing strength and friability results of the tablet batches prepared with 10 %w/w of the pre-
gelatinized starches can be attributed to their granule properties. Though their granules exhibited fair 
flowability, their higher particle consolidation must have ensured better compaction properties by promoting 
increased inter-particulate bonding upon compression (Oyi et al., 2009All the formulated tablets disintegrated 
within 15 min as specified by British Pharmacopoeia (BP 2009) for uncoated tablets, but the results showed a 
decrease in the disintegration time with the pre-gelatinized starches and also with increase in the concentration 
of the pre-gelatinized starches. The decrease in the disintegration times of the tablets formulated with the pre-
gelatinized starches could be as a result of the higher swelling ability of the pre-gelatinized starches. Starch pre-
gelatinization has been reported to increase the swelling ability of the starches and consequently decrease the 
disintegration times of tablets prepared with them by facilitating the absorption of large quantities of water into 
the tablet mass and the subsequent generation of a higher swelling force which would initiate the active 
mechanism of disintegration at a faster rate than the natural starch disintegrants (Guyot-Herman, 1992; 
Alebiowu and Itiola, 2003; Abdallah et al., 2016). 
 
 
Fig 3: Dissolution profiles of the different batches of the acetylsalicylic acid tablets (A-K) 
 
Results from the dissolution studies of the tablet 
batches showed a dissolution rate that is in direct 
correlation to the disintegration times of the tablets 
(Figure 3). There was an increase in dissolution rate 
with decrease in the disintegration times of the 
tablets. This is in line with the findings of some 
researchers who have maintained that disintegration 
times and dissolution are directly correlated as shorter 
disintegration times will invariably lead to faster and 
increased rate of dissolution (Rubeinstein and Wells 
1997; Iwuagwu et al., 2001). Tablets prepared with 
the pre-gelatinized cassava starch were comparable in 
their release profiles with those containing 
microcrystalline cellulose. Also, all the batches of the 
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tablets formulated achieved almost 100 % drug 
release within 60 min with all the batches of tablets 
passing the British Pharmacopoeia (BP 2003) 
dissolution test for tablets, which specifies that at 
least 70 % of the drug should be in solution after 45 
min. 
 
Conclusion: This study has shown that tablets 
prepared with the pre-gelatinized forms of the test 
starches were superior in some important tablet 
properties to those prepared with their native 
counterparts. Also the pre-gelatinized test starches 
compared favourably with microcrystalline cellulose, 
a known direct compression agent in their direct 
compression ability and drug release profiles 
especially at the concentration of 10 %w/w. 
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